| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/07/2008 | WO2008016678A2 Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid |
| 02/07/2008 | WO2008016664A2 Compositions and methods for treating cancer with dacarbazine nanoemulsions |
| 02/07/2008 | WO2008016602A2 Free base gacyclidine nanoparticles |
| 02/07/2008 | WO2008016490A2 Modified two-component gelation systems for the treatment of post-myocardial infarction |
| 02/07/2008 | WO2008016475A2 Immune response modifier compositions and methods |
| 02/07/2008 | WO2008016404A2 Parathyroid hormone analogues and uses thereof |
| 02/07/2008 | WO2008016297A1 Drug delivery device comprising a pharmaceutically or biologically active component and an infrared absorbing compound |
| 02/07/2008 | WO2008016260A1 A pharmaceutical composition for oral comprising fenofibrate and preparation method thereof |
| 02/07/2008 | WO2008016258A1 Nanoliposome using esterified lecithin and method for preparing the same, and composition for preventing or treating skin diseases comprising the same |
| 02/07/2008 | WO2008016172A1 Metastasis inhibitor |
| 02/07/2008 | WO2008016165A2 Liquid preparation |
| 02/07/2008 | WO2008016095A1 PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT |
| 02/07/2008 | WO2008016077A1 Adhesive preparation |
| 02/07/2008 | WO2008016016A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | WO2008015959A1 Pharmaceutical composition improved in absorption of pharmacologically active substance |
| 02/07/2008 | WO2008015686A1 Stable multiparticulate formulations of didanosine |
| 02/07/2008 | WO2008015583A1 Exhaust manifolds including heat shield assemblies |
| 02/07/2008 | WO2008015530A2 Stable solid oral formulation of pantoprazole |
| 02/07/2008 | WO2008015453A1 Antimicrobials |
| 02/07/2008 | WO2008015238A2 Subcutaneous implants releasing an active principle over an extended period of time |
| 02/07/2008 | WO2008015236A1 Subcutaneous implants releasing an active principle over an extended period of time |
| 02/07/2008 | WO2008015232A1 Subcutaneous implants releasing an active principle over an extended period of time |
| 02/07/2008 | WO2008015221A2 Multilayer orally disintegrating tablet |
| 02/07/2008 | WO2008015220A1 Granule and orally disintegrating tablet comprising oxycodone |
| 02/07/2008 | WO2008015203A2 Compositions of microparticles and granules for oral controlled release of substances for veterinary use |
| 02/07/2008 | WO2008015162A1 Gastro retentive delivery system |
| 02/07/2008 | WO2008015018A1 Delayed-release glucocorticoid treatment of rheumatoid disease |
| 02/07/2008 | WO2008015012A1 Microbubbles as drug delivery device |
| 02/07/2008 | WO2008014686A1 Formulation containing low molecular heparin for intraarticular injection |
| 02/07/2008 | WO2008014685A1 Formulation containing trehalose for intraarticular injection |
| 02/07/2008 | WO2008014610A1 Drug delivery compositions and methods of forming and using same |
| 02/07/2008 | WO2007147861A3 Sustained release formulations of aromatase inhibitors |
| 02/07/2008 | WO2007140189A3 Preparation and utility of substituted carboxylic acid compounds |
| 02/07/2008 | WO2007128478A3 Pharmaceutical composition |
| 02/07/2008 | WO2007121302A3 Antioxidant compositions for reducing odor in warming lubricant compositions |
| 02/07/2008 | WO2007120930A3 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives |
| 02/07/2008 | WO2007120687A3 Combination therapy for the treatment and improvement of scars |
| 02/07/2008 | WO2007098500A3 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| 02/07/2008 | US20080033402 Interface for medical infusion pump |
| 02/07/2008 | US20080033392 Gelled composite |
| 02/07/2008 | US20080033391 Two-Chamber Cartridge For Propellant-Free Metering Aerosols |
| 02/07/2008 | US20080033381 Absorbent Article Containing Fragrance |
| 02/07/2008 | US20080033366 Compressible intravascular embolization particles and related methods and delivery systems |
| 02/07/2008 | US20080033357 External Infusion Device with Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities |
| 02/07/2008 | US20080033059 Enteric Coating Compositions |
| 02/07/2008 | US20080033027 Drug combination pharmaceutical compositions and methods for using them |
| 02/07/2008 | US20080033009 Solid Pharmaceutical Formulation |
| 02/07/2008 | US20080032384 Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton |
| 02/07/2008 | US20080032350 Alpha-isomaltosylglucosaccharide-forming enzyme, process and uses of the same |
| 02/07/2008 | US20080032020 Center-filled chewing gum containing a deliverable form of calcium |
| 02/07/2008 | US20080031989 Tablet production method and tablet production apparatus |
| 02/07/2008 | US20080031970 Method of Promoting Natural Bypass |
| 02/07/2008 | US20080031966 Sustained release compositions for delivery of pharmaceutical proteins |
| 02/07/2008 | US20080031965 Oral Preparations and Process for Production Thereof |
| 02/07/2008 | US20080031964 Combination therapeutic compositions and method of use |
| 02/07/2008 | US20080031963 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| 02/07/2008 | US20080031962 Microencapsulation of Cells in Hydrogels Using Electrostatic Potentials |
| 02/07/2008 | US20080031961 Benefit agent containing delivery particle |
| 02/07/2008 | US20080031959 Anti-migraine oral spray formulations and methods |
| 02/07/2008 | US20080031958 Composition for accelerating bone fracture healing |
| 02/07/2008 | US20080031956 Bioimplant formulation |
| 02/07/2008 | US20080031955 Product Comprising a Beta-Lactam Antibiotic |
| 02/07/2008 | US20080031954 Modulation of angiogenesis by a-beta peptide fragments |
| 02/07/2008 | US20080031953 Composition And Method For Treating Or Preventing Psychiatric Symptom |
| 02/07/2008 | US20080031952 Nucleic Acid Comprising a Sequence Encoding a Modified Glutenin Polypeptide |
| 02/07/2008 | US20080031951 Compositions and methods for the inhibition of phospholipase A2 |
| 02/07/2008 | US20080031950 Novel anelgesic combination |
| 02/07/2008 | US20080031949 High dose orally dissolvable/disintegrable lyophilized dosage form |
| 02/07/2008 | US20080031948 admixed with hydroxyalkylcellulose, polyvinylacetate, blends of polyvinylacetate and polyvinylpyrrolidone, a vinylpyrrolidone copolymer and polyethylene oxide; enteric coating |
| 02/07/2008 | US20080031947 Orally dissolvable/disintegrable lyophilized dosage forms containing protected |
| 02/07/2008 | US20080031946 Low-Dose Tablets Having a Network of Polymers |
| 02/07/2008 | US20080031945 Gastro retentive delivery system |
| 02/07/2008 | US20080031944 Stabilization of lorazepam |
| 02/07/2008 | US20080031943 Immediate-release tablet formulations of a thrombin receptor antagonist |
| 02/07/2008 | US20080031942 Solid Preparation |
| 02/07/2008 | US20080031941 Gastric acid secretion inhibiting composition |
| 02/07/2008 | US20080031940 Quercetin-containing composition, methods of making, and methods of using |
| 02/07/2008 | US20080031939 Process for the preparation of armodafinil |
| 02/07/2008 | US20080031938 Biocidal materials for treatment against pathogens |
| 02/07/2008 | US20080031937 Amphoteric liposomes containing positive and negative membrane-based or membrane forming charge carriers and having an isoelectric point of between 4 and 7; stable at pH 4.2 and Ph 7.5; cationic lipid, anionic lipid, and neutral lipid; comprising cholesterol hemisuccinate |
| 02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
| 02/07/2008 | US20080031935 Cholinesterase Inhibitors In Liposomes And Their Production And Use |
| 02/07/2008 | US20080031933 Transparent transdermal nicotine delivery devices |
| 02/07/2008 | US20080031932 Transdermal atomoxetine formulations and associated methods |
| 02/07/2008 | US20080031931 Organotellurium and selenium-based antimicrobial formulations and articles |
| 02/07/2008 | US20080031929 Liquid bandage |
| 02/07/2008 | US20080031928 No laxation bulking system |
| 02/07/2008 | US20080031927 Solid oral dosage vitamin and mineral compositions |
| 02/07/2008 | US20080031926 Administering to birds and snimals in need of contraception an nicarbazin and a carrier; inhibition of zona pellucida protein C (ZPC), measuring ZPC, and stopping administration to reversibly restore ZPC; added to feed; nontoxic; efficiency |
| 02/07/2008 | US20080031922 comprising a core and a membrane encasing it; for controlling the initial burst of therapeutically active agent from a delivery system that consists of at least one elastomer; an implant, intravaginal, intracervical or intrauterine device or transdermal patch |
| 02/07/2008 | US20080031918 Barriers for polymeric coatings |
| 02/07/2008 | US20080031917 Bone graft substitute composition |
| 02/07/2008 | US20080031916 Dendrimer cross-linked collagen |
| 02/07/2008 | US20080031913 Method for manufacturing biomedical filler material rich-contained with growth factor |
| 02/07/2008 | US20080031910 Delivery system for an oral care substance |
| 02/07/2008 | US20080031907 Cosmetic and pharmaceutical foam |
| 02/07/2008 | US20080031903 Method of treating ocular infections |
| 02/07/2008 | US20080031901 Sustained release monoeximic formulations of opioid and nonopioid analgesics |
| 02/07/2008 | US20080031899 Nanoparticles for immunotherapy |
| 02/07/2008 | US20080031865 Product and process for liquefaction of mucus or sputum |